Rezafungin Acetate

5 trials 1 recruiting JAnti-infectives Orphan designation

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

1 Recruiting

4 Completed trials

3 Sponsors

8 Countries

Phase III

Phase II

Phase III/IV

Phase IV

Phase I (Other)

Phase III: 1 Phase II: 1 Phase III/IV: 1 Phase IV: 1 Phase I (Other): 1

Oversight events:

2 temporary halts 1 corrective measure across 2 trials

View oversight register →

Sponsors using this IMP

Mundipharma Research Limited 3 Fundacion Para La Investigacion Biomedica Del Hospital Universitario Ramon Y Cajal 1 Medical University Of Graz 1

All trials

5 total

Rezafungin plasma concentrations in patients with or without extracorporal treatments (ECMO ± RRT) (REZAFECT) Recruiting

2024-519789-37-00 Phase III/IV 1 country Medical University Of Graz
Pharmacokinetic Study of Rezafungin in Patients with Suspected Intra-Abdominal Candidiasis: Peritoneal Diffusion and Candicidal Activity Ended

2025-521854-40-00 Phase IV 1 country Fundacion Para La Investigacion Biomedica Del Hospital Universitario Ramon Y Caj…
Rezafungin for treatment of chronic pulmonary aspergillosis (CPA) in adults with limited treatment options Ended

2024-519575-26-00 Phase II 8 countries Mundipharma Research Limited
A Phase 1, Multicentre, Open-Label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single IV Dose of Rezafungin Acetat… Ended

2022-501985-23-00 Phase I (Other) 2 countries Mundipharma Research Limited
A Phase 3 Study of Rezafungin for Injection Versus the Standard Antimicrobial Regimen to Prevent Invasive Fungal Diseases in AdultsUndergoin… Ended

2024-514471-18-00 Phase III 5 countries Mundipharma Research Limited

Showing 1–5 of 5 trials

← All drugs A–Z